SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

Share Price is delayed by 15 minutes
Get Live Data
3.75    0.00 (0.00%)
Bid:
3.50
Ask:
4.00
Spread: 0.50 (14.286%)
Market Cap: £1.04m
SNT Live PriceLast checked at - London Stock Exchange

Intraday Sabien Tech. Share Chart

Warrant Exercise

26 Nov 2021 07:00

RNS Number : 6622T
Sabien Technology Group PLC
26 November 2021
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.

26 November 2021

Sabien Technology Group plc

("Sabien" or the "Company")

Warrant Exercise Notice and Total Voting Rights

Sabien Technology Group plc, a company focussed on building a portfolio of operations which, in combination, provide critical elements of the transition to a Green Economy, announces that it has received an exercise notice from investors in relation to 50,000 warrants.

The Company announced the issue of the warrants on 20 January 2021, which are exercisable at an exercise price of 30 pence per share following the 29 March 2021 300:1 share consolidation. Accordingly, pursuant to the warrant exercise notice, Sabien will issue 50,000 new ordinary shares of 3 pence each in the capital of the Company ("Ordinary Shares") (the "New Shares"). Application will be made for the New Shares to be admitted to trading on AIM and admission is expected to become effective on 2 December 2021 ("Admission"). 

Following Admission, the Company will have 14,720,168 Ordinary Shares in issue, each share carrying the right to one vote. The Company does not hold any Ordinary Shares in Treasury. Following Admission, the figure of 14,720,168 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Further Information:

Sabien Technology Group plc

Richard Parris, Executive Chairman

 

+44 20 7993 3700

 

Allenby Capital Limited (Nominated Adviser)

John Depasquale / Nick Harriss / Vivek Bhardwaj

 

+44 20 3328 5656

Peterhouse Capital Limited (Broker)

Duncan Vasey / Lucy Williams

+44 20 7469 0930

 

The person who arranged for the release of this announcement on behalf of the Company was Richard Parris, Executive Chairman.

A copy of this announcement will be available from the Company's website at www.sabien-tech.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEFESFUIEFSELF
Date   Source Headline
1st Oct 20127:00 amRNSPreliminary Statement of Final Results
30th Aug 20122:30 pmRNSRetirement of Chairman
10th Jul 20127:00 amRNSPost Close Trading Statement
7th Mar 20127:00 amRNSRe Contract
7th Feb 20127:00 amRNSHalf Yearly Report
1st Feb 20127:00 amRNSRe-organisation of Nominated Adviser and Broker
12th Jan 201212:20 pmRNSDirector Declaration
12th Jan 20129:27 amRNSCapital Reorganisation
9th Jan 20127:00 amRNSNotice of Results
5th Jan 20127:00 amRNSChange of Adviser
19th Dec 201110:54 amRNSDirector Declaration
29th Nov 201110:19 amRNSHolding(s) in Company
24th Nov 20117:00 amRNSResult of AGM
21st Nov 201110:26 amRNSHolding(s) in Company
17th Nov 201111:23 amRNSHolding(s) in Company
4th Nov 20111:50 pmRNSHolding(s) in Company
1st Nov 20117:00 amRNSAnnual Report and Accounts
7th Oct 20117:00 amRNSNew Contract Win
3rd Oct 20117:00 amRNSFinal Results
12th Sep 20117:00 amRNSNew Contract Win
25th Aug 20117:00 amRNSNew Contract Win
11th Jul 20117:00 amRNSPost Year End Trading Update
29th Jun 20111:12 pmRNSM2G sale to US Distributor
2nd Jun 201112:15 pmRNSNotice of Results
8th Apr 201111:28 amRNSM2G sale to US Distributor
2nd Mar 201111:44 amRNSHolding(s) in Company
1st Mar 201111:08 amRNSHolding(s) in Company
7th Feb 20117:00 amRNSHalf Yearly Report
5th Jan 20117:00 amRNSNotice of Results and Trading Update
26th Nov 20107:00 amRNSDirector/PDMR Shareholding
25th Nov 20107:00 amRNSResult of AGM
17th Nov 20107:00 amRNSAward of Contract
12th Nov 20104:12 pmRNSAnnual Financial Report
29th Oct 20107:00 amRNSPreliminary Results
18th Oct 20107:00 amRNSNotice of Results
15th Oct 20107:00 amRNSDirectorate Change
20th Sep 20107:00 amRNSAward of Contract
6th Aug 20107:00 amRNSAward of Contract
5th Jul 20107:00 amRNSAward of Contract
24th Jun 20107:00 amRNSAward of Contract
1st Jun 20107:00 amRNSTrading Statement
17th May 20107:00 amRNSChange of Adviser
1st Apr 201012:37 pmRNSGrant of options
25th Feb 20107:00 amRNSHalf Yearly Report
2nd Dec 20097:00 amRNSNew Contract Win
9th Nov 20097:00 amRNSAdjustment to number of warrants in issue
28th Oct 20097:00 amRNSPreliminary Results - 12 months ended 30 June 2009
14th Oct 20097:00 amRNSPlacing
7th Oct 20097:00 amRNSContract award
28th Sep 200911:40 amRNSAlliance Agreement with Jones Lang LaSalle

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.